Geoffrey Liu, Ernest Nadal, Shobhit Baijal, Alessandra Bulotta, Christina S Baik, Holger C. Thurm, Anna Polli, Makoto Nishio. "Impact of lorlatinib dose modifications on adverse event outcomes in the phase 3 CROWN study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.8590